Guo et al. have found that the deletion of the demethylase ALKBH5 of m6A will aggravate the occurrence of pancreatic cancer and the adverse clinicopathological characteristics [36]. This evidence concerns the gene ALKBH5 and familial pancreatic carcinoma.